Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL)

Oppenheimer & Co. Inc. acquired a new position in Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,669 shares of the company’s stock, valued at approximately $190,000.

A number of other hedge funds have also recently made changes to their positions in GRAL. FNY Investment Advisers LLC bought a new stake in shares of Grail in the 4th quarter worth approximately $26,000. New York State Common Retirement Fund bought a new stake in Grail during the 4th quarter valued at $59,000. Wilmington Savings Fund Society FSB bought a new stake in Grail during the 4th quarter valued at $64,000. Manchester Capital Management LLC bought a new stake in Grail during the 4th quarter valued at $123,000. Finally, China Universal Asset Management Co. Ltd. bought a new stake in Grail during the 4th quarter valued at $127,000.

Grail Price Performance

Shares of Grail stock opened at $32.88 on Monday. The company’s fifty day simple moving average is $30.64 and its two-hundred day simple moving average is $20.87. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.

Grail (NASDAQ:GRAL) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. On average, equities analysts expect that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on GRAL. Wolfe Research began coverage on shares of Grail in a report on Friday, November 15th. They set a “peer perform” rating for the company. Morgan Stanley began coverage on shares of Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target for the company.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.